Complement and dilated cardiomyopathy: A role of sublytic terminal complement complex-induced tumor necrosis factor-α synthesis in cardiac myocytes

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 449-457

  Zwaka, Thomas P ^a   Manolov, Dimitar ^a   Özdemir, Cüneyt ^a   Marx, Nikolaus ^a   Kaya, Ziya ^b   Kochs, Matthias ^a   Höher, Martin ^a   Hombach, Vinzenz ^a   Torzewski, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; GENETIC TRANSCRIPTION; HEART DILATATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MALE; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036969373     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64201-0     Document Type: Article

References (44)

1. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100
2. Martino TA, Liu P, Sole MJ: Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994, 74:182-188
3. Rose NR: Viral damage or "molecular mimicry " - placing the blame in myocarditis. Nat Med 2000, 6:631-632
4. Nakamura H, Yamamura T, Umemoto S, Fukuta S, Shioi T, Matsumori A, Sasayama S, Matsuzaki M: Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation 1996, 94:3348-3354
5. Neumann DA, Lane JR, Wulff SM, Allen GS, LaFond-Walker A, Herskowitz A, Rose NR: In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol 1992, 148:3806-3813
6. Schulze K, Becker BF, Schauer R, Schultheiss HP: Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation 1990, 81:959-969
7. Rose NR, Hill SL: The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol 1996, 80:92-99
8. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC: Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990, 82:8-16
9. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA: Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999, 99:1348-1354
10. Maisch B, Bauer E, Cirsi M, Kochsiek K: Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 1993, 87:IV49-1V65
11. Liu PP, Opavsky MA: Viral myocarditis: receptors that bridge the cardiovascular with the immune system? Circ Res 2000, 86:253-254
12. Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R: Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Prog Cardiovasc Dis 1998, 41:25-30
13. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995, 83:793-802
14. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 1998, 274:R577-R595
15. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997, 81:627-635
16. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, Inada T, Ohtani S, Hasegawa K, Fujiwara T, Sasayama S: Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 1996, 54:217-225
17. Satoh M, Nakamura M, Saitoh H, Satoh H, Maesawa C, Segawa I, Tashiro A, Hiramori K: Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 1999, 99:3260-3265
18. Beletskaia LV, Baranova FS, Mogilevskii GM, Kurenkova LG, Kazakov EN, Kormer A, Smirnova IV, Khalimova ZA, Dmitriev AA, Chestukhin VV: Immunopathologic study of the myocardium in dilated cardiomyopathy. Arkh Patol 1992, 54:24-27
19. Hillarp A, Wiklund H, Thern A, Dahlback B: Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins. J Immunol 1997, 158:1315-1323
20. Mondragon-Palomino M, Pinera D, Nicholson-Weller A, Laclette JP: Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9. J Mol Evol 1999, 49:282-289
21. Volanakis JE: Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982, 389:235-250
22. Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C: Processes in atherogenesis: complement activation. Atherosclerosis 1997, 132: 131-138
23. Lachmann PJ, Davies A: Complement and immunity to viruses. Immunol Rev 1997, 159:69-77
24. Lubinsky J, Wang L, Mastellos D, Sahu A, Lambris JD, Friedman HM: In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 1999, 190:1637-1646
25. Anderson DR, Carthy CM, Wilson JE, Yang D, Devine DV, McManus BM: Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers. J Virol 1997, 71:8841-8845
26. Fearon DT: The complement system and adaptive immunity. Semin Immunol 1998, 10:355-361
27. Carroll RC: The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998, 16: 545-568
28. Niculescu F, Badea T, Rus H: Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 1999, 142: 47-56
29. Morgan BP: Effects of the membrane attack complex of complement on nucleated cells. Curr Top Microbiol Immunol 1992, 178:115-140
30. Lovett DH, Haensch GM, Goppelt M, Resch K, Gemsa D: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 1987, 138: 2473-2480
31. Benzaquen LR, Nicholson-Weller A, Halperin JA: Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 1994, 179:985-992
32. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D, Bowyer D: Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 1996, 16:673-677
33. Niculescu F, Rus H, van Biesen T, Shin ML: Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complex is G protein dependent. J Immunol 1997, 158:4405-4412
34. Roberts WC, Siegel RJ, McManus BM: Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987, 60:1340-1355
35. Ferrans VJ: Pathologic anatomies of the dilated cardiomyopathies. Am J Cardiol 1989, 64:9C-11C
36. Edwards WD: Cardiomyopathies. Hum Pathol 1987, 18:625-635
37. Piper HM, Probst I, Schwartz P, Hutter FJ, Spieckermann PG: Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 1982, 14:397-412
38. Piper HM, Jacobson SL, Schwartz P: Determinants of cardiomyocyte development in long-term primary culture. J Mol Cell Cardiol 1988, 20:825-835
39. Thompson RA, Lachmann PJ: Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med 1970, 131:629-641
40. Lachmann PJ, Thompson RA: Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med 1970, 131:643-657
41. Marx N, Mach F, Sauty A, Leung JH, Saraf MN, Ransohoff RM, Libby P, Plutzky J, Luster AD: Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 2000, 164:6503-6507
42. Comstock KL, Krown KA, Page MT, Martin D, Ho P, Pedraza M, Castro EN, Nakajima N, Glembotski CC, Quintana PJ, Sabbadini RA: LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 1998, 30:2761-2775
43. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J: C-Reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20:2094-2099
44. Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, Fairweather D, Holers VM, Rose NR: Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol 2001, 2:739-745